Literature DB >> 11522346

Two glycoforms are present in the GPI-membrane anchor of the surface antigen 1 (P30) of Toxoplasma gondii.

C F Zinecker1, B Striepen, H Geyer, R Geyer, J F Dubremetz, R T Schwarz.   

Abstract

SAG1 (P30) is the major surface protein of the Toxoplasma gondii tachyzoite, the life cycle stage associated with the acute phase of infection. The protein is inserted into the parasite's plasma membrane by a glycosyl-phosphatidylinositol anchor, a modification that is present on all T. gondii surface proteins characterized so far. Here we describe a detailed structural analysis of this anchor. GPI anchor peptides were isolated from [3H]glucosamine labeled purified P30 by protease digestion and phase partitioning. Neutral glycans were prepared from this material by dephosphorylation and deamination. Two glycoforms were characterized by gel filtration and high performance ion exchange chromatography in combination with exoglycosidase treatment. Both forms were shown to carry an N-acetylgalactosamine bound to the first mannose of the conserved three-mannosyl core. Glycan B carries an additional terminal hexose linked to GalNAc. To identify the nature of this hexose, bulk anchor peptide was prepared and glycans were purified by aminopropyl-HPLC. Highly purified glycans were subjected to MALDI-TOF-MS and, after derivatization, to FAB-MS and methylation linkage analysis. The structures of the two anchors found on SAG1 were determined to be: Man-alpha1,2-Man-alpha1,6-Man-[GalNAc-beta1,4-]-alpha1,4-GlcN-PI and Man-alpha1,2-Man-alpha1,6-Man [Glc-alpha1,4-GalNAc-beta1,4-]-alpha1,4-GlcN-PI. Comparison of these structures with free GPI glycolipid precursors characterized in T. gondii suggests that core modification of the anchor takes place prior to transfer to the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522346     DOI: 10.1016/s0166-6851(01)00313-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  Extracellular Toxoplasma gondii tachyzoites metabolize and incorporate unnatural sugars into cellular proteins.

Authors:  Lidia A Nazarova; Roxanna J Ochoa; Krysten A Jones; Naomi S Morrissette; Jennifer A Prescher
Journal:  Microbes Infect       Date:  2015-12-11       Impact factor: 2.700

Review 2.  High-sensitivity analytical approaches for the structural characterization of glycoproteins.

Authors:  William R Alley; Benjamin F Mann; Milos V Novotny
Journal:  Chem Rev       Date:  2013-03-27       Impact factor: 60.622

3.  Membrane topology and transient acylation of Toxoplasma gondii glycosylphosphatidylinositols.

Authors:  Jürgen Kimmel; Terry K Smith; Nahid Azzouz; Peter Gerold; Frank Seeber; Klaus Lingelbach; Jean-François Dubremetz; Ralph T Schwarz
Journal:  Eukaryot Cell       Date:  2006-08

4.  Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.

Authors:  Kamy Hosseinian Khosroshahi; Fatemeh Ghaffarifar; Zohre Sharifi; Sushila D'Souza; Abdolhosein Dalimi; Zuhair M Hassan; Fariba Khoshzaban
Journal:  Parasitol Res       Date:  2012-02-21       Impact factor: 2.289

5.  Clostridium septicum alpha-toxin is active against the parasitic protozoan Toxoplasma gondii and targets members of the SAG family of glycosylphosphatidylinositol-anchored surface proteins.

Authors:  Michael J Wichroski; Jody A Melton; Carolyn G Donahue; Rodney K Tweten; Gary E Ward
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 6.  Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.

Authors:  Isabelle Coppens
Journal:  Nat Rev Microbiol       Date:  2013-10-28       Impact factor: 60.633

7.  The Apicomplexa-specific glucosamine-6-phosphate N-acetyltransferase gene family encodes a key enzyme for glycoconjugate synthesis with potential as therapeutic target.

Authors:  Marta Cova; Borja López-Gutiérrez; Sara Artigas-Jerónimo; Aida González-Díaz; Giulia Bandini; Steven Maere; Lorenzo Carretero-Paulet; Luis Izquierdo
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

8.  Apart From Rhoptries, Identification of Toxoplasma gondii's O-GlcNAcylated Proteins Reinforces the Universality of the O-GlcNAcome.

Authors:  Moyira Osny Aquino-Gil; Mattis Kupferschmid; Hosam Shams-Eldin; Jörg Schmidt; Nao Yamakawa; Marlène Mortuaire; Frédéric Krzewinski; Stéphan Hardivillé; Edgar Zenteno; Christian Rolando; Fabrice Bray; Eduardo Pérez Campos; Jean-François Dubremetz; Yobana Perez-Cervera; Ralph T Schwarz; Tony Lefebvre
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-20       Impact factor: 5.555

Review 9.  Modulation of autophagy as a therapeutic strategy for Toxoplasma gondii infection.

Authors:  Ao Cheng; Huanan Zhang; Baike Chen; Shengyao Zheng; Hongyi Wang; Yijia Shi; Siyao You; Ming Li; Liping Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.